CA
AVNS

Clearstead Advisors’s Avanos Medical AVNS Stock Holding History

Clearstead Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100 Buy
+4
New +$94 ﹤0.01% 3354
2026
Q1 		– Sell
-10
Closed -$113 – 2302
2025
Q4 		$113 Sell
10
-1,258
-99% -$14.4K ﹤0.01% 2501
2025
Q3 		$14.7K Buy
1,268
+874
+222% +$10.2K ﹤0.01% 1776
2025
Q2 		$4.82K Buy
+394
New +$4.96K ﹤0.01% 2116

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Clearstead Advisors's AVNS Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Avanos Medical (AVNS) in Q2 2026: 4 shares worth $100. The stake represents ﹤0.01% of the portfolio and ranks #3354 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in AVNS as recently as Q4 2025.

Clearstead Advisors first reported a position in AVNS in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.7K in Q3 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Clearstead Advisors held 4 shares of Avanos Medical worth $100 as of Q2 2026.
  • Avanos Medical was a new Clearstead Advisors position in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3354 holding.
  • Clearstead Advisors first reported a position in Avanos Medical in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Advisors's Avanos Medical position peaked at $14.7K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.